6 results on '"Armin Shirvani"'
Search Results
2. Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: Clinical practice guideline
- Author
-
Homayoun Nikkhah, Saeed Karimi, Hamid Ahmadieh, Mohsen Azarmina, Majid Abrishami, Hossein Ahoor, Yousef Alizadeh, Hasan Behboudi, Narsis Daftarian, Mohammad Hossein Dehghan, Morteza Entezari, Fereydoun Farrahi, Heshmatollah Ghanbari, Khalil Ghasemi Falavarjani, Mohammad Ali Javadi, Reza Karkhaneh, Siamak Moradian, Masoud Reza Manaviat, Morsal Mehryar, Ramin Nourinia, Mohammad Mehdi Parvaresh, Alireza Ramezani, Alireza Ragati Haghi, Mohammad Riazi-Esfahani, Masoud Soheilian, Mohsen Shahsavari, Hossein-Ali Shahriari, Zhale Rajavi, Sare Safi, Armin Shirvani, Saeed Rahmani, Hamideh Sabbaghi, Mojgan Pakbin, Bahareh Kheiri, and Hossein Ziaei
- Subjects
Age-related Macular Degeneration ,Anti-vascular Endothelial Growth Factor ,Intravitreal Injection ,Diabetic Macular Edema ,Retinal Vein Occlusion ,Ophthalmology ,RE1-994 - Abstract
Purpose: To provide the clinical recommendations for the administration of intravitreal anti-vascular endothelial growth factor (VEGF) drugs especially bavacizumab for ocular vascular diseases including diabetic macular edema, neovascular age-related macular degeneration, myopic choroidal neovascularization, retinal vein occlusion and central serous chorioretinopathy. Methods: Twenty clinical questions were developed by the guideline technical committee. Relevant websites and databases were searched to find out the pertinent clinical practice guidelines to answer the questions. The technical committee provided possible answers (scenarios) according to the available evidences for each question. All scenarios along with their levels of evidence and the supported articles were sent to the experts for external review. If the experts did not agree on any of the scenarios for one particular clinical question, the technical committee reviewed all scenarios and their pertinent evidences and made the necessary decision. After that, the experts were asked to score them again. All confirmed scenarios were gathered as the final recommendations. Results: All the experts agreed on at least one of the scenarios. The technical committee extracted the agreed scenario for each clinical question as the final recommendation. Finally, 56 recommendations were developed for the procedure of intravitreal anti-VEGF injection and their applications in the management of ocular vascular diseases. Conclusion: The implementation of this guideline can standardize the management of the common ocular vascular diseases by intravitreal injection of anti-VEGF agents. It can lead to better policy-making and evidence-based clinical decision by ophthalmologists and optimal evidence based eye care for patients.
- Published
- 2018
- Full Text
- View/download PDF
3. Clinical practice guidelines for prevention, diagnosis and management of early and delayed-onset ocular injuries due to mustard gas exposure
- Author
-
Zhale Rajavi, Sare Safi, Mohammad Ali Javadi, Mohammad Reza Jafarinasab, Sepehr Feizi, Mohammadreza Sedighi Moghadam, Khosrow Jadidi, Mahmoud Babaei, Armin Shirvani, Alireza Baradaran-Rafii, Hossein Mohammad-Rabei, Hossein Ziaei, Mohammad Ghassemi-Broumand, Siamak Delfaza Baher, Mostafa Naderi, Mahmoodreza Panahi-Bazaz, Siamak Zarei-Ghanavati, Shahriar Hanjani, Hassan Ghasemi, Ramin Salouti, Mojgan Pakbin, and Bahareh Kheiri
- Subjects
Clinical Practice Guidelines ,Eye Injury ,Iran ,Mustard Gas ,Ophthalmology ,RE1-994 - Abstract
Purpose: To develop clinical practice guidelines (CPGs) for prevention, diagnosis, treatment and follow-up of ocular injuries caused by exposure to mustard gas. Methods: The clinical questions were designed by the guideline team. Websites and databases including National Guidelines Clearinghouse, National Institute for Clinical Excellence, Cochrane, and PubMed were searched to find related CPGs and explore possible answers to the clinical questions. Since there were no relevant CPGs in the literature, related articles in Persian and English languages were extracted. Each article along with its level of evidence was summarized. Additionally, hand search was performed by looking the reference list of each article. Consequently, recommendations were developed considering the clinical benefits and side effects of each therapeutic modality. The recommendations were re-evaluated in terms of customization criteria. All recommendations along with the related evidence were scored from 1 to 9 by experts from all medical universities of Iran. The level of agreement among the experts was evaluated by analyzing the given scores. Results: The agreement was achieved for all recommendations. The experts suggested a number of minor modifications which were applied to the recommendations. Finally, CPGs were developed with 98 recommendations under three major domains including prevention of injury, diagnosis and management of the acute and delayed-onset mustard gas ocular injuries. Conclusion: Considering the lack of CPGs for the prevention, diagnosis, and management of mustard gas-induced keratitis, these recommendations would be useful to prevent the serious ocular complications of mustard gas and standardize eye care services to the affected individuals.
- Published
- 2017
- Full Text
- View/download PDF
4. Diabetic retinopathy clinical practice guidelines: Customized for Iranian population
- Author
-
Zhale Rajavi, Sare Safi, Mohammad Ali Javadi, Mohsen Azarmina, Siamak Moradian, Morteza Entezari, Ramin Nourinia, Hamid Ahmadieh, Armin Shirvani, Saeid Shahraz, Alireza Ramezani, Mohammad Hossein Dehghan, Mohsen Shahsavari, Masoud Soheilian, Homayoun Nikkhah, Hossein Ziaei, Hasan Behboudi, Fereydoun Farrahi, Khalil Ghasemi Falavarjani, Mohammad Mehdi Parvaresh, Hamid Fesharaki, Majid Abrishami, Nasser Shoeibi, Mansour Rahimi, Alireza Javadzadeh, Reza Karkhaneh, Mohammad Riazi-Esfahani, Masoud Reza Manaviat, Alireza Maleki, Bahareh Kheiri, and Faegheh Golbafian
- Subjects
Clinical Practice Guidelines ,Diabetic Retinopathy ,Iran ,Ophthalmology ,RE1-994 - Abstract
Purpose: To customize clinical practice guidelines (CPGs) for management of diabetic retinopathy (DR) in the Iranian population. Methods: Three DR CPGs (The Royal College of Ophthalmologists 2013, American Academy of Ophthalmology [Preferred Practice Pattern 2012], and Australian Diabetes Society 2008) were selected from the literature using the AGREE tool. Clinical questions were designed and summarized into four tables by the customization team. The components of the clinical questions along with pertinent recommendations extracted from the above-mentioned CPGs; details of the supporting articles and their levels of evidence; clinical recommendations considering clinical benefits, cost and side effects; and revised recommendations based on customization capability (applicability, acceptability, external validity) were recorded in 4 tables, respectively. Customized recommendations were sent to the faculty members of all universities across the country to score the recommendations from 1 to 9. Results: Agreed recommendations were accepted as the final recommendations while the non-agreed ones were approved after revision. Eventually, 29 customized recommendations under three major categories consisting of screening, diagnosis and treatment of DR were developed along with their sources and levels of evidence. Conclusion: This customized CPGs for management of DR can be used to standardize the referral pathway, diagnosis and treatment of patients with diabetic retinopathy.
- Published
- 2016
- Full Text
- View/download PDF
5. Customized clinical practice guidelines for management of adult cataract in Iran
- Author
-
Zhaleh Rajavi, Mohammad Ali Javadi, Narsis Daftarian, Sare Safi, Farhad Nejat, Armin Shirvani, Hamid Ahmadieh, Saeid Shahraz, Hossein Ziaei, Hamidreza Moein, Behzad Fallahi Motlagh, Sepehr Feizi, Alireza Foroutan, Hassan Hashemi, Seyed Javad Hashemian, Mahmoud Jabbarvand, Mohammad Reza Jafarinasab, Farid Karimian, Hossein Mohammad-Rabei, Mehrdad Mohammadpour, Nader Nassiri, Mahmoodreza Panahi-Bazaz, Mohammad Reza Rohani, Mohammad Reza Sedaghat, and Kourosh Sheibani
- Subjects
Adult ,Cataract ,Iran ,Practice Guideline ,Ophthalmology ,RE1-994 - Abstract
Purpose: To customize clinical practice guidelines (CPGs) for cataract management in the Iranian population. Methods: First, four CPGs (American Academy of Ophthalmology 2006 and 2011, Royal College of Ophthalmologists 2010, and Canadian Ophthalmological Society 2008) were selected from a number of available CPGs in the literature for cataract management. All recommendations of these guidelines, together with their references, were studied. Each recommendation was summarized in 4 tables. The first table showed the recommendation itself in clinical question components format along with its level of evidence. The second table contained structured abstracts of supporting articles related to the clinical question with their levels of evidence. The third table included the customized recommendation of the internal group respecting its clinical advantage, cost, and complications. In the fourth table, the internal group their recommendations from 1 to 9 based on the customizing capability of the recommendation (applicability, acceptability, external validity). Finally, customized recommendations were sent one month prior to a consensus session to faculty members of all universities across the country asking for their comments on recommendations. Results: The agreed recommendations were accepted as conclusive while those with no agreement were discussed at the consensus session. Finally, all customized recommendations were codified as 80 recommendations along with their sources and levels of evidence for the Iranian population. Conclusion: Customization of CPGs for management of adult cataract for the Iranian population seems to be useful for standardization of referral, diagnosis and treatment of patients.
- Published
- 2015
- Full Text
- View/download PDF
6. Diabetic retinopathy clinical practice guidelines: Customized for Iranian population
- Author
-
Hasan Behboudi, Masoud Reza Manaviat, Alireza Maleki, Mohammad Mehdi Parvaresh, Mohsen Azarmina, Ramin Nourinia, Saeid Shahraz, Hossein Ziaei, Mohammad Ali Javadi, Armin Shirvani, Mansour Rahimi, Mohsen Shahsavari, Zhale Rajavi, Morteza Entezari, Faegheh Golbafian, Nasser Shoeibi, Fereydoun Farrahi, Majid Abrishami, Mohammad Riazi-Esfahani, Bahareh Kheiri, Siamak Moradian, Sare Safi, Mohammad Hossein Dehghan, Hamid Ahmadieh, Hamid Fesharaki, Homayoun Nikkhah, Reza Karkhaneh, Khalil Ghasemi Falavarjani, Alireza Javadzadeh, Alireza Ramezani, and Masoud Soheilian
- Subjects
medicine.medical_specialty ,Referral ,Alternative medicine ,Iran ,Iranian population ,External validity ,03 medical and health sciences ,0302 clinical medicine ,lcsh:Ophthalmology ,Ophthalmology ,medicine ,Clinical Practice Guidelines ,Diabetic Retinopathy ,business.industry ,Diabetic retinopathy ,Evidence-based medicine ,medicine.disease ,Australian diabetes ,Clinical Practice ,lcsh:RE1-994 ,Family medicine ,030221 ophthalmology & optometry ,030211 gastroenterology & hepatology ,business - Abstract
Purpose: To customize clinical practice guidelines (CPGs) for management of diabetic retinopathy (DR) in the Iranian population. Methods: Three DR CPGs (The Royal College of Ophthalmologists 2013, American Academy of Ophthalmology [Preferred Practice Pattern 2012], and Australian Diabetes Society 2008) were selected from the literature using the AGREE tool. Clinical questions were designed and summarized into four tables by the customization team. The components of the clinical questions along with pertinent recommendations extracted from the above-mentioned CPGs; details of the supporting articles and their levels of evidence; clinical recommendations considering clinical benefits, cost and side effects; and revised recommendations based on customization capability (applicability, acceptability, external validity) were recorded in 4 tables, respectively. Customized recommendations were sent to the faculty members of all universities across the country to score the recommendations from 1 to 9. Results: Agreed recommendations were accepted as the final recommendations while the non-agreed ones were approved after revision. Eventually, 29 customized recommendations under three major categories consisting of screening, diagnosis and treatment of DR were developed along with their sources and levels of evidence. Conclusion: This customized CPGs for management of DR can be used to standardize the referral pathway, diagnosis and treatment of patients with diabetic retinopathy.
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.